Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta₂-agonist maintenance medications

By Hauber A. Brett   Mohamed Ateesha F.   Johnson F. Reed   Meddis David   Wagner Samuel   O'Dowd Liza  

Allergy and Asthma Proceedings, Vol. 30, Iss. 2, 2009-03 ,pp. : 139-147

OceanSide Publications, Inc

Access to resources Recommend Favorite

The long-acting beta-agonist controversy: A clinical dilemma

By Lang David M.   Davis Ray S.  

Allergy and Asthma Proceedings, Vol. 28, Iss. 2, 2007-03 ,pp. : 136-144

OceanSide Publications, Inc

Access to resources Recommend Favorite

The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma

By Mansfield Lyndon E.  

Allergy and Asthma Proceedings, Vol. 29, Iss. 2, 2008-03 ,pp. : 103-108

OceanSide Publications, Inc

Access to resources Recommend Favorite

Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 μg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids

By Nathan Robert A.   Nolte Hendrik   Pearlman David S.    

Allergy and Asthma Proceedings, Vol. 31, Iss. 4, 2010-07 ,pp. : 269-279

OceanSide Publications, Inc

Access to resources Recommend Favorite

Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy

By Hagiwara May   Delea Thomas E.   Stanford Richard H.   Stempel David A.  

Allergy and Asthma Proceedings, Vol. 31, Iss. 3, 2010-05 ,pp. : 203-210

OceanSide Publications, Inc

Access to resources Recommend Favorite